Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. (Q36329468)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

endocannabinoids

0 references

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

Raffaella Barbero

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

Vincenzo Di Marzo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Miolo A

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

The Veterinary Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

173

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

21-30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

A proposed autacoid mechanism controlling mastocyte behaviour

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Cannabinoid receptors and the regulation of immune response

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Mast cells: beyond IgE.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Control of pain initiation by endogenous cannabinoids.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Are opioids effective in relieving neuropathic pain?

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Cannabimimetic fatty acid derivatives in cancer and inflammation

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Endovanilloid signaling in pain

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Molecular architecture of the vanilloid receptor. Insights for drug design

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

The clinical picture of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Physiology of pain

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Update of the NGF saga

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Nerve growth factor: from neurotrophin to neurokine

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Topical capsaicin--a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Endocannabinoid degradation, endotoxic shock and inflammation.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

CB2 cannabinoid receptor-mediated peripheral antinociception

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Inhibition of pain responses by activation of CB(2) cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

What is the physiological function of mast cells?

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Endocannabinoids

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Cannabinoid modulation of peripheral autonomic and sensory neurotransmission

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Increased Expression of Vanilloid Receptor 1 on Myelinated Primary Afferent Neurons Contributes to the Antihyperalgesic Effect of Capsaicin Cream in Diabetic Neuropathic Pain in Mice

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Anandamide and vanilloid TRPV1 receptors

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Cannabinoid agonists attenuate capsaicin-induced responses in human skin

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Differential roles of CB1 and CB2 cannabinoid receptors in mast cells

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

A neural pathway for itch.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Hyperalgesia due to nerve damage: role of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Itch: scratching more than the surface

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Pain modulation by release of the endogenous cannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Endocannabinoids and related fatty acid derivatives in pain modulation

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Topical capsaicin therapy in humans with hemodialysis-related pruritus

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Pathobiology of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016/J.TVJL.2005.10.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TVJL.2005.10.003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856 AND SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36329468&oldid=1519385314"